Latest news with #dialysis
SBS Australia
2 days ago
- Health
- SBS Australia
When Home Heals: Dialysis and the Power of Staying on Country
For many Yolŋu people, being forced to leave Galiwin'ku for dialysis has meant separation from family, country, and culture - sometimes for years, sometimes forever. Chronic kidney disease, largely caused by lifestyle changes introduced through Western foods, has taken a devastating toll. For generations, Yolŋu people followed the rhythms of the seasons, knowing when and what to eat to stay strong and healthy. Traditional foods were naturally low in sugar and highly nutritious. But the shift to store-bought foods, soft drinks, and processed foods has led to widespread chronic disease - something that was once rare in these communities. In the past, when the winds come this way, we know what to eat. It's been passed over from my grandfather. What we feel through air, it's part of the grandfather that passed over to us, so we know exactly what to eat when the season comes. Charlie Dhamarrandji, Dialysis Patient In this episode, Dr. Sarah Hanieh speaks with Charlie Yebarrarr Dhamarrandji who shares his personal journey with chronic kidney failure and receiving dialysis treatment, and Kat Baxter, a dialysis nurse from Purple House, living on country in Galiwin'ku. Together, they discuss what it means to receive dialysis on country, the reality of chronic disease in remote communities, and how Yolŋu knowledge and traditions continue to play a vital role in health and healing. Two Worlds, One Health is created by Dr Sarah Hanieh Host : Dr Sarah Hanieh Production assistance : Lindy Marlow Artwork: Ruth Gulamanda Dhurrkay and Rickisha Banba Gurruwiwi Music : Djutjuti Nha Djamarrkuli, Shepherdson College, Galiwin'ku, Department of Education, Northern Territory. Mixed: Max Gosford Photos credit: Lindy Marlow Thanks to Joel Supple for her guidance. This podcast was recorded on the lands of the Yolŋu people in Galiwin'ku. I pay my respect to their Elders, past and present, and acknowledge their ongoing connection to the land, water, and culture Links:
Daily Mail
3 days ago
- Health
- Daily Mail
Footy star Richelle Cranston reveals the disgraceful comments she gets from fans as she waits desperately for a transplant to save her life
Footy star Richelle Cranston has revealed the awful comments and questions she receives online as she undergoes dialysis while hoping for a transplant that will end her long and draining battle with deadly kidney disease. The 35-year-old was forced to retire in 2023 after playing 60 AFLW matches for Melbourne, Geelong and the Western Bulldogs, and she gave her fans a sad parting message after her last game. 'My health has sort of deteriorated. It's been a really hard year - kidney disease,' she said when the Dogs were knocked out of the finals that November. 'I'll probably start dialysis in January [2024] so there was really no option for me [to keep playing]. 'I'll focus on my health - if anyone's got a kidney, hit me up!' Cranston is still on dialysis, and still waiting for the news that a donor has been found. As if life wasn't tough enough for Cranston, she also has to deal with ignorant and awful comments like this one from trolls on social media Her kidneys only had 12 per cent of normal function when she retired from footy and now she has to restrict herself to taking in no more than 1.5 litres of fluid a day, as well as spending eight hours hooked up to a dialysis machine by a catheter in her abdomen. And on top of all that, she is dealing with shocking and ignorant comments about her condition on social media. In one video she posted to Instagram, she reacts to a commenter who asked, 'If you killed it [your kidney] why should they give you another one?' 'So I didn't kill my kidney, I have a chronic illness, through no fault of my own,' she explained. 'Some people just get sick, and comments like this just prove we need more awareness.' In another clip, Cranston fires back at comments including, 'I'm not being rude here, but you've only got five years on dialysis avenue', 'All reversible, get into herbs and prayer', 'Try a grape diet, only grapes for three solid weeks', and 'It can be reversed don't get caught in that specialist syndrome'. She sums up her reaction to those with the simple reply, 'Advice about as useful as my kidneys.' When another commenter told her, 'You don't look sick,' the former Bulldogs star posted a video of her with her dialysis machine and the caption, 'Chronic illness isn't visible but it's always there.' The former Dogs, Cats and Demons star has somehow managed to keep working out in the gym (pictured) - but even that has been used against her online Cranston has been able to stay in great shape with regular gym workouts despite her health battle, but trolls have even found a way to use that to insult her, with one writing, 'You're on anavar [the steroid Anavir] or something stop effing lying omg.' 'So a few people think I'm on steroids, which is kind of a compliment, so thanks,' Cranston replied. 'I'm in kidney failure and literally need a machine to keep me alive, so not sure why I'd take steroids. 'I played professional sport for eight years, where I got tested for performance-enhancing drugs. 'And how is this the body of someone on steroids?' she concludes, pointing out the catheter emerging from her midriff. In another post, she reveals messages from people asking 'Are you a tran [trans]???' and 'What is your gender?' before replying, 'Strong women really do bring out the insecurity in some people.' There are roughly 1400 Australians waiting for a kidney transplant, with a median wait time of 2.2 years, according to Kidney Health Australia. However, Cranston could be on the list for far longer due to a quirk in her physical make-up. 'I try not to think about the transplant too much ... since my blood type is really rare,' she told News Corp. 'It would be great if I got a transplant but I don't want to get my hopes up.' Thankfully, the trolls with their shocking comments are only a very small portion of the followers she's attracted since starting to document her health battle online. She also has to deal with breathtaking comments about her gender 'Ninety five per cent of the feedback I get is really positive,' she said. 'It's a lot of people either with families who have got someone going through it, or just found out they have it and [are] looking for insight. 'There are definitely days when I think "this sucks", but I also don't want it to ruin my life. 'There are people suffering way more than I am.' Cranston thought the disease 'couldn't be that bad' when she was first diagnosed, because she 'felt great at the time'. But then she went blind in one eye at footy training as the condition increased her blood pressure so much it burst blood vessels behind her eye.
CBS News
4 days ago
- Health
- CBS News
She shared her story of life on dialysis. Now she has a new kidney: "God found me the perfect match."
After 10 years on dialysis, and just days after the story of her long wait for a transplant was featured on "CBS Sunday Morning," LaQuayia "LQ" Goldring, 35, has a new kidney. Before receiving her transplant, Goldring spent up to four and a half hours a day hooked up to a home dialysis machine. "Every day I wake up, I'm thanking God that my feet even hit the ground and that my eyes open and I can still breathe on my own," she said in an interview in January. In her interview, Goldring described the challenges of life as one of roughly 500,000 Americans dependent on dialysis to stay alive, and detailed the uncomfortable shortcomings of care provided by for-profit clinics. She received the treatment at home and said dialysis clinics left her with no control over her care, treating her like a "check." A seven-month CBS News investigation looked at how two for-profit companies grew into what experts term a "duopoly," dominating the market nationwide. Critics have accused the firms of prioritizing profits over the care of patients on dialysis. The two largest for-profit companies in the dialysis industry, Fresenius and DaVita, dispute those criticisms. Fresenius told CBS News in a statement that the company maintains an "unwavering focus on improving quality of life, strengthening clinical outcomes, and extending the lifespan of those we have the privilege to serve." DaVita said in a statement that its "dedicated clinicians consistently deliver high-quality, individualized care in a complex clinical and regulatory environment." Less than a week after her interview aired in June, Goldring received a life-saving kidney transplant through a living donor. At the age of 3, cancer caused both of Goldring's kidneys to fail. She received her first transplant as a teenager from a deceased donor, but when it lost function in 2014, she had to go back on dialysis. In her campaign for a new kidney, Goldring stopped at nothing — posting billboards in her community and becoming an outspoken advocate for those suffering from advanced kidney disease. On Monday, June 20, she got the call that she was a match for a kidney transplant. By that Friday, she was on the operating table. "They asked me if I was scared or had any concerns, and I said none," Goldring told CBS News in a phone interview. "God found me the perfect match." Goldring said she plans to continue sharing her story, emphasizing the importance of living donations. Goldring's kidney was from an unidentified man from Georgia who chose to become a living donor. "Living and non-living donations saved my life," Goldring says. "I want to keep spreading that message. People don't have enough information." Dr. Malay Shah of the University of Kentucky's Transplant Center performed Goldring's surgery, describing it as "absolutely necessary." About one-third of all kidney transplants performed each year in the U.S. are living-donor kidney transplants. And Shah says living-donor kidney transplants have the best outcomes and don't require as long of a wait time for the patient. "When a living donor match came about, it was like winning the lottery for her," said Shah. While Goldring has been back to the hospital a few times since her transplant, her doctors say that's normal with recovery. A kidney transplant is the only option for patients to get off of dialysis. Of the half-million people in the U.S. on dialysis at any given time, nearly 90,000 have qualified for a spot on the waiting list for a kidney transplant, and 11 people die every day waiting for a kidney, according to the United Network for Organ Sharing. "My hope is that more people will hear about [my story] and more donors will come forth," says Goldring.
Yahoo
16-07-2025
- Business
- Yahoo
Constellation Kidney Group Marks 50 Years of Dialysis Innovation, Introducing KidneyOne to Power the Next Generation of Kidney Care
RICHMOND, Va., July 16, 2025--(BUSINESS WIRE)--Constellation Kidney Group (CKG), a global portfolio of businesses under Miram Solutions within the Perseus Operating Group (Perseus) of Constellation Software Inc. (TSX: CSU), proudly commemorates 50 years of dialysis technology innovation, honoring the legacy of Quantitative Medical Systems Inc. (QMS), founded in Oakland, California in 1976. Acquired by Perseus in 2013, QMS laid the foundation for what is now a global leader in integrated clinical, operational, and analytics solutions for kidney care providers. To mark this milestone, CKG is unveiling a refreshed brand identity and introducing its next-generation product ecosystem: KidneyOne, a fully integrated dialysis management platform; CKG Intelligence, a powerful analytics suite, including the Renal AI predictive care solution; and CKG Exchange, a robust interoperability hub for the future, connecting data across the kidney care continuum. "Celebrating 50 years is a testament to the incredible legacy of QMS and the ongoing commitment of Constellation Kidney Group to empower dialysis providers with technology that makes a meaningful difference," said David Abbott, General Manager of CKG. "As part of the Constellation Software family, our ethos has always been to acquire and nurture vertical market software businesses for the long term, ensuring continuous innovation and lasting value for our customers." CKG's KidneyOne platform brings together its market-leading solutions into a single, unified ecosystem — enhancing workflows, delivering actionable insights, and helping dialysis providers optimize care, operations, and compliance across global markets. "KidneyOne gives providers a smarter, more connected way to run their dialysis operations while supporting better outcomes and reducing costs," said Chris Lutz, General Manager, CKG US. "By uniting best-in-class solutions with AI-driven analytics and integrated workflows in a single platform, we're defining the next generation of dialysis software built to scale for long-term growth." The 50th anniversary milestone reflects CKG's enduring mission to advance kidney care through purpose-built technology, reliability, and long-term partnership. Visit the company's updated website to learn more: About Constellation Kidney Group Constellation Kidney Group (CKG) is a global leader in dialysis technology, delivering purpose-built clinical, financial, and operational solutions that empower kidney care providers worldwide. Formed through the acquisition of leading software innovators beginning in 2013, CKG brings together decades of expertise in KidneyOne — an integrated platform offering modern EHR applications, data-driven intelligence, and seamless interoperability through CKG Exchange. CKG is a global portfolio of businesses under Miram Solutions within the Perseus Operating Group of Constellation Software Inc. (TSX: CSU), and is committed to advancing kidney care through innovation, reliability, and long-term partnership. Learn more at View source version on Contacts Chris Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
National Post
16-07-2025
- Business
- National Post
Constellation Kidney Group Marks 50 Years of Dialysis Innovation, Introducing KidneyOne to Power the Next Generation of Kidney Care
Article content RICHMOND, Va. — Constellation Kidney Group (CKG), a global portfolio of businesses under Miram Solutions within the Perseus Operating Group (Perseus) of Constellation Software Inc. (TSX: CSU), proudly commemorates 50 years of dialysis technology innovation, honoring the legacy of Quantitative Medical Systems Inc. (QMS), founded in Oakland, California in 1976. Acquired by Perseus in 2013, QMS laid the foundation for what is now a global leader in integrated clinical, operational, and analytics solutions for kidney care providers. Article content To mark this milestone, CKG is unveiling a refreshed brand identity and introducing its next-generation product ecosystem: Article content Article content KidneyOne, a fully integrated dialysis management platform; CKG Intelligence, a powerful analytics suite, including the Renal AI predictive care solution; and CKG Exchange, a robust interoperability hub for the future, connecting data across the kidney care continuum. Article content 'Celebrating 50 years is a testament to the incredible legacy of QMS and the ongoing commitment of Constellation Kidney Group to empower dialysis providers with technology that makes a meaningful difference,' said David Abbott, General Manager of CKG. 'As part of the Constellation Software family, our ethos has always been to acquire and nurture vertical market software businesses for the long term, ensuring continuous innovation and lasting value for our customers.' Article content CKG's KidneyOne platform brings together its market-leading solutions into a single, unified ecosystem — enhancing workflows, delivering actionable insights, and helping dialysis providers optimize care, operations, and compliance across global markets. Article content 'KidneyOne gives providers a smarter, more connected way to run their dialysis operations while supporting better outcomes and reducing costs,' said Chris Lutz, General Manager, CKG US. 'By uniting best-in-class solutions with AI-driven analytics and integrated workflows in a single platform, we're defining the next generation of dialysis software built to scale for long-term growth.' Article content The 50th anniversary milestone reflects CKG's enduring mission to advance kidney care through purpose-built technology, reliability, and long-term partnership. Visit the company's updated website to learn more: About Constellation Kidney Group Constellation Kidney Group (CKG) is a global leader in dialysis technology, delivering purpose-built clinical, financial, and operational solutions that empower kidney care providers worldwide. Formed through the acquisition of leading software innovators beginning in 2013, CKG brings together decades of expertise in KidneyOne — an integrated platform offering modern EHR applications, data-driven intelligence, and seamless interoperability through CKG Exchange. CKG is a global portfolio of businesses under Miram Solutions within the Perseus Operating Group of Constellation Software Inc. (TSX: CSU), and is committed to advancing kidney care through innovation, reliability, and long-term partnership. Learn more at Article content Article content
